Simplex Trading
PPBT

Simplex Trading’s Purple Biotech PPBT Stock Holding History

Simplex Trading’s Portfolio PPBT Stock Details PPBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$808 Buy
200
+180
+900% +$971 ﹤0.01% 8644
2025
Q4 		$131 Buy
+20
New +$145 ﹤0.01% 8288
2025
Q1 		– Sell
-140
Closed -$6K – 9401
2024
Q4 		$6K Buy
+140
New +$5.39K ﹤0.01% 7524
2022
Q3 		– Sell
-18
Closed -$8K – 10668
2022
Q2 		$8K Sell
18
-17
-49% -$10.2K ﹤0.01% 8490
2022
Q1 		$27K Sell
35
-67
-66% -$43.2K ﹤0.01% 7903
2021
Q4 		$78K Buy
102
+100
+5,000% +$85.2K ﹤0.01% 6629
2021
Q3 		$1K Hold
2
– – ﹤0.01% 9674
2021
Q2 		$1K Buy
+2
New +$1.84K ﹤0.01% 9853
2021
Q1 		– Hold
0
– – – 8287
2020
Q4 		– Hold
0
– – – 7997

Other funds holding PPBT

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $240M AUM
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Simplex Trading's PPBT Position: Q1 2026 in Review

Simplex Trading reduced its Purple Biotech (PPBT) stake by 35% in Q1 2026, selling an estimated $1.76K and leaving 597 shares worth $2.41K. The position accounts for ﹤0.01% of the portfolio, ranked #8302.

Simplex Trading first reported a position in PPBT in Q4 2020 and has held it in 13 quarters since. The position peaked at $34K in Q1 2023. 15 funds tracked by Wall St. Rank hold PPBT as of Q1 2026.

  • Simplex Trading held 597 shares of Purple Biotech worth $2.41K as of Q1 2026.
  • Simplex Trading sold 326 Purple Biotech shares in Q1 2026, an estimated $1.76K.
  • Purple Biotech made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8302 holding.
  • Simplex Trading first reported a position in Purple Biotech in Q4 2020 and has held it in 13 quarters since.
  • Simplex Trading's Purple Biotech position peaked at $34K in Q1 2023.
  • 15 funds tracked by Wall St. Rank held Purple Biotech as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.